Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 225

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 225
---
 sale of the shares of our common stock offered by this prospectus could be effected in one or more of the following methods:

| ● | ordinary brokers’ transactions; |

| ● | transactions involving cross or block trades; |

| ● | through brokers, dealers, or underwriters who may act solely as agents; |

| ● | “at the market” into an existing market for our common stock; |

| ● | in other ways not involving market makers or established business markets, including direct sales to purchasers 
 or sales effected through agents;                                                                               |

| ● | in privately negotiated transactions; or |

| ● | any combination of the foregoing. |

The Selling Stockholder may
also sell or dispose of shares of common stock included in this prospectus under any applicable exemption from registration under the
U.S. Securities Act, including Rule 144, if or when any such exemption is available and may be relied upon by the Selling Stockholder
to effect such sale or disposition.

In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state’s registration or qualification requirement is available and complied with.

Yorkville is an “underwriter”
within the meaning of Section 2(a)(11) of the Securities Act.

| 128 |

Except as set forth above,
we know of no existing arrangements between Yorkville and any other stockholder, broker, dealer, underwriter or agent relating to the
sale or distribution of the shares of our common stock offered by this prospectus.

Brokers, dealers, underwriters
or agents participating in the distribution of the shares of our common stock offered by this prospectus may receive compensation in the
form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by
Yorkville through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of shares of our
common stock sold by Yorkville may be less than or in excess of customary commissions. Neither we nor Yorkville can presently estimate
the amount of compensation that any agent will receive from any purchasers of shares of our common stock sold by Yorkville.

We may from time to time file
with the SEC one or more supplements to this prospectus or amendments to the Registration Statement of which this